Jumei Shi
12PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Mar 14, 2026
METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation.Guanli Wang, Xuejie Gao, Hui Zhang
|Mar 09, 2026
Targeting endosomal trafficking-mediated antigen escape to resensitize myeloma to CAR-T therapy.Zhuning Wang, Guanli Wang, Yujie Liu
|Jan 19, 2025
Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis.Xuejie Gao, Qilin Feng, Qikai Zhang
|Nov 28, 2023
The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway.Yingcong Wang, Sanfeng Dong, Ke Hu
|Nov 09, 2023
TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage.Shuaikang Chang, Wenqin Xiao, Yongsheng Xie
|May 13, 2022
Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma.Yongsheng Xie, Yingcong Wang, Zhijian Xu
Pageof 2
